Empirical Simulation and In Silico Evaluation of an Ethically Governed, AI-Enhanced CRISPR Prime Editing Framework for TOR1A Mutation Correction in Dystonia
Abstract
Hereditary dystonia, particularly the isolated form of early onset, is often caused by a deletion of the GAG in the TOR1A gene, leading to a dysfunctional TorsinA protein and severe motor impairments. In this study, we investigate an AI-enhanced CRISPR prime editing framework designed for the precise correction of the TOR1A mutation. Our framework integrates the generation of candidate pegRNA with an empirical simulation of training data, enabling the tuning of a random forest model that predicts editing efficiency. This approach generates robust quantitative outputs (validation R2 score of 0.701). SHapley Additive exPlanations (SHAP) revealed that GC content (mean SHAP = 0.22) and off-target risk (mean SHAP = 0.18) were the strongest drivers of predicted efficiency. The GC content showed strong positive correlations with melting temperature (r = 0.75) and guide efficiency (r = 0.82). By linking the simulated modeling work to the practical challenges of genetic neurosurgery in dystonia, a proof-of-concept framework is presented that is both ethically governed and clinically pertinent. This work looks toward a future of scalpel-less surgery by laying a foundation for future integration with empirical datasets and more advanced deep learning techniques.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Specific mutations in genes responsible for Alzheimer and for Duchenne Muscular Dystrophy introduced by Base editing and PRIME editing.
Joël Rousseau, Cedric Happi Mbakam, … Jacques P. Tremblay·bioRxiv·Jul 31, 2020
- Allele-specific targeting of mutant TOR1A by the compact CRISPR/NmCas9 system in DYT1 dystonia with high fidelity
Junjiao Wu, Yu Tang·bioRxiv·Apr 22, 2024
- Prime Editing Enables High-Efficiency Correction of the Ryr1 T4706M Mutation: A Promising Therapeutic Approach for RyR1-Related Myopathies
Kelly Godbout, Joël Rousseau, … Jacques P. Tremblay·bioRxiv·Sep 12, 2025
- Effective in vivo RNA base editing via engineered cytidine deaminase APOBECs fused with PUF proteins
Wenjian Han, Bo Yuan, … Zilong Qiu·Nature CommunicationsPeer-reviewed·Nov 4, 2025
- Engineered CRISPR-Base Editors as a Permanent Treatment for Familial Dysautonomia
Shuqi Yun, Anil K. Chekuri, … Christiano R. R. Alves·bioRxiv·Nov 27, 2024
- Optimizing twin prime editing components for scalable genome editing and therapy in spinocerebellar ataxia type 3
Lee Wha Gwon, Jung Bae Seong, … Seung Hwan Lee·Molecular Therapy — Nucleic AcidsPeer-reviewed·Jun 17, 2026